More importantly, JMJD2B or JMJD2C overexpression induced transformed phenotypes in non-cancerous breast cells, whereas their downregulation in breast cancer cells inhibited cell proliferation in vitro or tumorigenesis in xenograft mouse models [62]–[65]. This evidence concerns the gene KDM4B and breast carcinoma.